Allergan recalls textured breast implant tied to rare cancer
WASHINGTON — Breast implant maker Allergan issued a worldwide recall Wednesday for certain textured models after regulators alerted the company to a heightened cancer risk with the devices.
The U.S. Food and Drug Administration said it called for the removal after new information showed Allergan’s Biocell breast implants with a textured surface were tied to the vast majority of cases of a rare form of lymphoma. The move follows similar action in France, Australia, and Canada.
Read Original Article: Allergan recalls textured breast implant tied to rare cancer »
